| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $683K | -27.1% | +12.5% |
| R&D Expense | $33.0M | -12.9% | +113.7% |
| SG&A Expense | $5.5M | -25.3% | +36.3% |
| Operating Income | -$37.8M | +14.7% | -100.3% |
| Income Tax | $0 | — | — |
| Net Income | -$33.7M | +15.6% | -111.0% |
| EPS (Basic) | -$0.63 |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $72.2M | +58.7% | +119.0% |
| Short-term Investments | $300.3M | -13.7% | +60.0% |
| Accounts Receivable | $683K | -27.1% | +12.5% |
| Current Assets | $389.0M | -7.0% | +71.2% |
| Total Assets | $391.2M | -7.0% | +68.1% |
| Current Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$102.6M | — | — |
| Capital Expenditures | $111K | — | — |
| Investing Cash Flow | -$152.4M | — | — |
| Financing Cash Flow | $1.3M | — | — |
| Free Cash Flow | -$102.8M | — | — |
| +90.9% |
| EPS (Diluted) | -$0.63 | +14.9% | +90.9% |
| $11.9M |
| +9.0% |
| +9.5% |
| Total Liabilities | $12.6M | +7.1% | +3.9% |
| Stockholders' Equity | $378.6M | -7.4% | +336.2% |